UBS Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $440M | Sell |
6,130,298
-498,915
| -8% | -$38.4M | 0.07% | 298 |
|
|
2025
Q4 | $526M | Sell |
6,629,213
-973,527
| -13% | -$76.7M | 0.09% | 218 |
|
|
2025
Q3 | $573M | Buy |
7,602,740
+944,560
| +14% | +$64.7M | 0.09% | 210 |
|
|
2025
Q2 | $459M | Sell |
6,658,180
-1,747,737
| -21% | -$115M | 0.08% | 242 |
|
|
2025
Q1 | $570M | Sell |
8,405,917
-1,508,924
| -15% | -$90.3M | 0.1% | 192 |
|
|
2024
Q4 | $445M | Buy |
9,914,841
+3,613,845
| +57% | +$203M | 0.08% | 223 |
|
|
2024
Q3 | $396M | Sell |
6,300,996
-734,006
| -10% | -$42.8M | 0.09% | 222 |
|
|
2024
Q2 | $415M | Sell |
7,035,002
-1,027,078
| -13% | -$64.2M | 0.1% | 191 |
|
|
2024
Q1 | $643M | Buy |
8,062,080
+732,562
| +10% | +$56M | 0.16% | 119 |
|
|
2023
Q4 | $579M | Sell |
7,329,518
-364,616
| -5% | -$26M | 0.17% | 117 |
|
|
2023
Q3 | $537M | Sell |
7,694,134
-842,844
| -10% | -$59.7M | 0.19% | 110 |
|
|
2023
Q2 | $590M | Buy |
8,536,978
+1,563,275
| +22% | +$111M | 0.2% | 111 |
|
|
2023
Q1 | $518M | Sell |
6,973,703
-353,723
| -5% | -$29.7M | 0.19% | 111 |
|
|
2022
Q4 | $683M | Buy |
7,327,426
+913,885
| +14% | +$88.2M | 0.26% | 77 |
|
|
2022
Q3 | $612M | Sell |
6,413,541
-907,766
| -12% | -$89.9M | 0.27% | 76 |
|
|
2022
Q2 | $678M | Buy |
7,321,307
+198,472
| +3% | +$19.4M | 0.28% | 74 |
|
|
2022
Q1 | $721M | Sell |
7,122,835
-111,574
| -2% | -$11.7M | 0.24% | 91 |
|
|
2021
Q4 | $746M | Sell |
7,234,409
-92,005
| -1% | -$8.5M | 0.21% | 106 |
|
|
2021
Q3 | $622M | Sell |
7,326,414
-730,840
| -9% | -$61.2M | 0.2% | 113 |
|
|
2021
Q2 | $672M | Sell |
8,057,254
-67,811
| -0.8% | -$5.55M | 0.22% | 100 |
|
|
2021
Q1 | $611M | Buy |
8,125,065
+528,955
| +7% | +$38.5M | 0.2% | 112 |
|
|
2020
Q4 | $519M | Buy |
7,596,110
+828,301
| +12% | +$53.9M | 0.18% | 131 |
|
|
2020
Q3 | $395M | Sell |
6,767,809
-747,479
| -10% | -$46.5M | 0.15% | 142 |
|
|
2020
Q2 | $488M | Sell |
7,515,288
-572,176
| -7% | -$36M | 0.21% | 116 |
|
|
2020
Q1 | $480M | Buy |
8,087,464
+762,010
| +10% | +$50.9M | 0.23% | 101 |
|
|
2019
Q4 | $544M | Buy |
7,325,454
+266,827
| +4% | +$18.7M | 0.19% | 125 |
|
|
2019
Q3 | $445M | Sell |
7,058,627
-1,270,153
| -15% | -$75.3M | 0.17% | 133 |
|
|
2019
Q2 | $454M | Buy |
8,328,780
+2,404,427
| +41% | +$129M | 0.17% | 134 |
|
|
2019
Q1 | $320M | Buy |
5,924,353
+1,242,484
| +27% | +$76.7M | 0.13% | 170 |
|
|
2018
Q4 | $307M | Buy |
4,681,869
+643,514
| +16% | +$48M | 0.14% | 164 |
|
|
2018
Q3 | $318M | Sell |
4,038,355
-206,131
| -5% | -$14.7M | 0.13% | 181 |
|
|
2018
Q2 | $273M | Buy |
4,244,486
+316,137
| +8% | +$20.8M | 0.12% | 193 |
|
|
2018
Q1 | $244M | Sell |
3,928,349
-1,259,847
| -24% | -$90.4M | 0.11% | 208 |
|
|
2017
Q4 | $376M | Sell |
5,188,196
-6,395,374
| -55% | -$465M | 0.15% | 155 |
|
|
2017
Q3 | $942M | Buy |
11,583,570
+454,492
| +4% | +$36M | 0.44% | 31 |
|
|
2017
Q2 | $895M | Buy |
11,129,078
+475,396
| +4% | +$37.5M | 0.46% | 30 |
|
|
2017
Q1 | $836M | Buy |
10,653,682
+1,455,785
| +16% | +$116M | 0.46% | 33 |
|
|
2016
Q4 | $726M | Buy |
9,197,897
+2,728,362
| +42% | +$221M | 0.4% | 39 |
|
|
2016
Q3 | $576M | Buy |
6,469,535
+168,673
| +3% | +$15.9M | 0.34% | 54 |
|
|
2016
Q2 | $603M | Buy |
6,300,862
+220,785
| +4% | +$22M | 0.38% | 39 |
|
|
2016
Q1 | $631M | Buy |
6,080,077
+225,846
| +4% | +$22M | 0.42% | 34 |
|
|
2015
Q4 | $572M | Buy |
5,854,231
+962,840
| +20% | +$94.3M | 0.37% | 44 |
|
|
2015
Q3 | $472M | Buy |
4,891,391
+458,052
| +10% | +$48.2M | 0.33% | 47 |
|
|
2015
Q2 | $465M | Buy |
4,433,339
+248,994
| +6% | +$25.4M | 0.31% | 57 |
|
|
2015
Q1 | $432M | Buy |
4,184,345
+229,657
| +6% | +$23.2M | 0.3% | 67 |
|
|
2014
Q4 | $381M | Buy |
+3,954,688
| New | +$348M | 0.27% | 73 |
|
Other funds holding CVS
VCM
VPM
UBS Group's CVS Position: Q1 2026 in Review
UBS Group reduced its CVS Health (CVS) stake by 7.5% in Q1 2026, selling an estimated $38.4M and leaving 6,130,298 shares worth $440M. The position accounts for 0.07% of the portfolio, ranked #298.
UBS Group first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $942M in Q3 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- UBS Group held 6,130,298 shares of CVS Health worth $440M as of Q1 2026.
- UBS Group sold 498,915 CVS Health shares in Q1 2026, an estimated $38.4M.
- CVS Health made up 0.07% of UBS Group's portfolio in Q1 2026, its #298 holding.
- UBS Group first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
- UBS Group's CVS Health position peaked at $942M in Q3 2017.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.